HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Langedijk, J. P. M. Articles by Meloen, R. H. Search for Related Content PubMed PubMed Citation Articles by Langedijk, J. P. M. Articles by Meloen, R. H. Agricola Articles by Langedijk, J. P. M. Articles by Meloen, R. H.

Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1

¹ Central Veterinary Institute, P.O. Box 65, 8200 AB Lelystad
² Human Retrovirus Laboratory, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands
and³ DuPont, Biotechnology Systems, North Billerica, Massachusetts, U.S.A.

Monoclonal antibodies (MAbs) raised against a 15-mer peptide representing the centre of the principal neutralization domain of human immunodeficiency virus type 1 (strain BH10) showed wide variations in neutralizing activity against the homologous strain. The nature of this difference in neutralizing activity was studied by measuring antibody concentration, their affinity for peptide and specificity, by reaction with peptides which differed in the extent of sequence overlap, length and the presence of single amino acid replacements. All MAbs bound to approximately the same region in the principal neutralization domain, within the sequence RIQRGPGRAFV. The peptides with which each antibody was able to react differed by only a few amino acids. The neutralizing activity of each MAb preparation was related to its afinity and concentration; the affinity is related in part to the fine structure of the epitope recognized. MAbs with high affinity for the peptide tended to react only with peptides in which amino acid replacements did not affect the -turn potential of the peptide, whereas the reactivity of MAbs with low affinity was relatively insensitive to amino acid replacements affecting the -turn potential.

Received 26 March 1991; accepted 28 June 1991.

This article has been cited by other articles:

				F. Kostolanský, E. Varecková, T. Betáková, V. Mucha, G. Russ, and S. A. Wharton The strong positive correlation between effective affinity and infectivity neutralization of highly cross-reactive monoclonal antibody IIB4, which recognizes antigenic site B on influenza A virus haemagglutinin J. Gen. Virol., July 1, 2000; 81(7): 1727 - 1735. [Abstract] [Full Text]

				E. M. Rakowicz-Szulczynska, B. Jackson, A. M. Szulczynska, and M. Smith Human Immunodeficiency Virus Type 1-Like DNA Sequences and Immunoreactive Viral Particles with Unique Association with Breast Cancer Clin. Vaccine Immunol., September 1, 1998; 5(5): 645 - 653. [Abstract] [Full Text]

				G. Wu, R. MacKenzie, P. J. Durda, and P. Tsang The Binding of a Glycoprotein 120 V3 Loop Peptide to HIV-1 Neutralizing Antibodies. STRUCTURAL IMPLICATIONS J. Biol. Chem., November 17, 2000; 275(47): 36645 - 36652. [Abstract] [Full Text] [PDF]